Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0896 | 1 | 1 |
Plasmodium vivax | RNA helicase-1, putative | 0.0896 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0569 | 0.5547 | 0.5547 |
Loa Loa (eye worm) | helix-loop-helix DNA-binding domain-containing protein | 0.0296 | 0.1838 | 0.1838 |
Brugia malayi | Kringle domain containing protein | 0.0405 | 0.3316 | 0.3316 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0896 | 1 | 1 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.0315 | 0.2101 | 0.2101 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0896 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0569 | 0.5547 | 0.5547 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0896 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0193 | 0.044 | 0.044 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0622 | 0.627 | 0.627 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.0566 | 0.5514 | 0.5514 |
Echinococcus multilocularis | max protein X | 0.0296 | 0.1838 | 0.1838 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0622 | 0.627 | 0.627 |
Onchocerca volvulus | 0.0473 | 0.4241 | 0.4241 | |
Loa Loa (eye worm) | hypothetical protein | 0.0566 | 0.5514 | 0.5514 |
Brugia malayi | hypothetical protein | 0.0193 | 0.044 | 0.044 |
Loa Loa (eye worm) | hypothetical protein | 0.0569 | 0.5547 | 0.5547 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0896 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0405 | 0.3316 | 0.1538 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.0566 | 0.5514 | 0.5514 |
Schistosoma mansoni | bhlhzip transcription factor bigmax | 0.0296 | 0.1838 | 0.1838 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.0315 | 0.2101 | 0.2101 |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.0566 | 0.5514 | 0.5514 |
Onchocerca volvulus | 0.0569 | 0.5547 | 0.5547 | |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0446 | 0.3878 | 0.3878 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0896 | 1 | 1 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0896 | 1 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.0405 | 0.3316 | 0.2361 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0896 | 1 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0315 | 0.2101 | 0.2101 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0566 | 0.5514 | 0.5514 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.0622 | 0.627 | 0.627 |
Brugia malayi | Helix-loop-helix DNA-binding domain containing protein | 0.0296 | 0.1838 | 0.1838 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.0566 | 0.5514 | 0.5514 |
Brugia malayi | Protein kinase domain containing protein | 0.0446 | 0.3878 | 0.3878 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.0566 | 0.5514 | 0.5514 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0896 | 1 | 0.5 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0896 | 1 | 1 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0896 | 1 | 1 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0896 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0566 | 0.5514 | 0.5514 |
Schistosoma mansoni | bhlhzip transcription factor bigmax | 0.0296 | 0.1838 | 0.1838 |
Onchocerca volvulus | Deterin homolog | 0.0566 | 0.5514 | 0.5514 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0896 | 1 | 1 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0896 | 1 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0405 | 0.3316 | 0.3316 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0896 | 1 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0569 | 0.5547 | 0.5547 |
Onchocerca volvulus | 0.0405 | 0.3316 | 0.3316 | |
Loa Loa (eye worm) | hypothetical protein | 0.0896 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0405 | 0.3316 | 0.3316 |
Brugia malayi | Trypsin family protein | 0.0569 | 0.5547 | 0.5547 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0896 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0566 | 0.5514 | 0.5514 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0622 | 0.627 | 0.627 |
Echinococcus granulosus | max protein X | 0.0296 | 0.1838 | 0.1838 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0896 | 1 | 0.5 |
Onchocerca volvulus | 0.0566 | 0.5514 | 0.5514 | |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0896 | 1 | 1 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0622 | 0.627 | 0.627 |
Schistosoma mansoni | hypothetical protein | 0.0405 | 0.3316 | 0.3316 |
Leishmania major | hypothetical protein, conserved | 0.0405 | 0.3316 | 0.1538 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0405 | 0.3316 | 0.3316 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0896 | 1 | 1 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0896 | 1 | 1 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0566 | 0.5514 | 0.5514 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0622 | 0.627 | 0.627 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.0315 | 0.2101 | 0.2101 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0896 | 1 | 0.5 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.0566 | 0.5514 | 0.5514 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 8.3 ug ml-1 | Antimycobacterial activity against Mycobacterium tuberculosis | ChEMBL. | 22280816 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.